Table 4. Summary of the patients who were eligible for the survival analysis.

	Pachychoroid neovasculopathy	Neovascular AMD
Number of patients	22	86
Age (years)	68.7 ± 8.5	74.1 ± 8.2
Sex (male:female)	5:17	27:59
Choroidal vascular hyperpermeability	15 (68.2%)	15 (17.4%)
Subfoveal choroidal thickness (μm)	314 ± 58	227 ± 103
Polypoidal legion	11 (50.0%)	41 (47.7%)
Dry macula after loading dose	20 (90.9%)	72 (83.7%)

AMD: age-related macular degeneration.